推薦產品
product name
TGF-β RI激酶抑制剂VI，SB431542, InSolution, ≥97%
品質等級
化驗
≥97% (HPLC)
形狀
liquid
製造商／商標名
Calbiochem®
儲存條件
OK to freeze
desiccated (hygroscopic)
protect from light
運輸包裝
ambient
儲存溫度
−20°C
InChI
1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)
InChI 密鑰
FHYUGAJXYORMHI-UHFFFAOYSA-N
一般說明
一种细胞渗透性三芳基咪唑化合物，经证明可有效抑制NIH 3T3细胞中组成性活性ALK4、ALK5或ALK7的载体介导表达后的细胞Smad2磷酸化（10 µM抑制剂抑制>90%），而在表达活性ALK1、2、3或6的NIH 3T3培养物中，TGF-βⅠ型受体的其他成员对Smad1磷酸化几乎没有影响。 当在无细胞激酶分析中直接测试时，SB431542被证明能有效抑制ALK4和ALK5的活性（IC50分别为140 nM和94 nM），而对包括ALK2和ALK6在内的24种其他激酶（IC50在10 µM ATP存在下为≥10 µM）没有效力或大大降低效力。据报道，当与PD0325901（目录号444966）和噻唑维文（目录号420220）一起使用时，4-TF诱导的成纤维细胞培养产生人类IPSC的效率提高了>200倍。
包裝
用惰性气体包装
警告
毒性：刺激性（B）
外觀
100 mM (5 mg/119 µl) SB431542（目录号616461）在DMSO中的溶液。
重構
初次融化后，等分并冷冻（-20°C）。
其他說明
Ikushima, H., et al. 2009.Cell Stem Cell5, 504.
Lin, T., et al. 2009.Nat. Methods6, 805.
Maherali, N. and Hochedlinger, K., 2009.Curr.Biol.19, 1718.
Callahan, J.F., et al. 2002.J. Med. Chem.45, 999.
Inman, G.J., et al. 2002.Mol.Pharmacol.62, 65.
Laping, N.J., et al. 2002.Mol.Pharmacol.62, 58.
Lin, T., et al. 2009.Nat. Methods6, 805.
Maherali, N. and Hochedlinger, K., 2009.Curr.Biol.19, 1718.
Callahan, J.F., et al. 2002.J. Med. Chem.45, 999.
Inman, G.J., et al. 2002.Mol.Pharmacol.62, 65.
Laping, N.J., et al. 2002.Mol.Pharmacol.62, 58.
法律資訊
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
儲存類別代碼
10 - Combustible liquids
水污染物質分類（WGK）
WGK 1
閃點（°F）
188.6 °F - (refers to pure substance)
閃點（°C）
87 °C - (refers to pure substance)
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。
客戶也查看了
Mine Koprulu et al.
The Journal of clinical endocrinology and metabolism, 107(4), 1065-1077 (2021-12-08)
Biological and translational insights from large-scale, array-based genetic studies of fat distribution, a key determinant of metabolic health, have been limited by the difficulty in linking predominantly noncoding variants to specific gene targets. Rare coding variant analyses provide greater confidence
Jorian D Hapeman et al.
BMC ecology and evolution, 23(1), 39-39 (2023-08-22)
In spite of extensive research, cancer remains a major health problem worldwide. As cancer progresses, cells acquire traits that allow them to disperse and disseminate to distant locations in the body - a process known as metastasis. While in the
Chao-Min Cheng et al.
The Journal of pathology, 240(1), 38-49 (2016-05-29)
MicroRNAs (miRNAs) are involved in the tumourigenesis of various cancers by regulating their downstream targets. To identify the changes of miRNAs in oral squamous cell carcinoma (OSCC), we investigated the expression profiles of miRNAs in 40 pairs of OSCC specimens
Wanyi Tang et al.
Cell reports, 38(10), 110486-110486 (2022-03-10)
Recent technological advancements on stem cell differentiation induction have been making great progress in stem cell research, regenerative medicine, and therapeutic applications. However, the risk of off-target differentiation limits the wide application of stem cell therapy strategies. Here, we report
Celia Sequera et al.
Cancers, 12(8) (2020-08-23)
The complexity of hepatocellular carcinoma (HCC) challenges the identification of disease-relevant signals. C3G, a guanine nucleotide exchange factor for Rap and other Ras proteins, plays a dual role in cancer acting as either a tumor suppressor or promoter depending on
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務